Superworth

Spectral AI profit margin MDAI

Gross, operating and net profit as a share of revenue over the last twelve months, from 2023.

Net margin, 12 months
−65.5%
Operating margin, 12 months
−77.2%
Net margin on a year earlier
−14.1 pts
Peer median
8.4%

Over the twelve months to Jun 30, 2026, Spectral AI kept −65.5% of its revenue as net profit, with an operating margin of −77.2% and a gross margin of 42.9%.

The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−38.5%−43.8%45.4%
FY2024−51.2%−22.3%44.9%
FY2023n/a−71.9%43.6%
FY2022n/an/an/a
FY2021n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−65.5%−14.1 pts−77.2%
Q1 FY26−82.0%−51.7 pts−57.2%
Q4 FY25−38.5%+12.7 pts−43.8%
Q3 FY25−70.0%−29.2 pts−32.2%
Q2 FY25−51.4%+38.5 pts−18.2%
Q1 FY25−30.2%n/a−17.8%
Q4 FY24−51.2%n/a−22.3%
Q3 FY24−40.8%+43.9 pts−30.8%
Q2 FY24−89.8%−64.4 pts−51.8%
Q1 FY24n/an/a−63.3%
Q4 FY23n/an/a−71.9%
Q3 FY23−84.6%n/a−62.7%

Against its peers

Companies in Medical - Instruments & Supplies nearest Spectral AI's size, closest first, today.

CompanyProfit margin
MDAISpectral AI−65.5%
NEPHNephros8.4%
APTAlpha Pro Tech6.8%
KEQUKewaunee Scientific3.0%
PDEXPro DEX17.6%
UTMDUtah Medical Products29.0%
INFUInfuSystem6.0%
EMBCEmbecta8.6%
Peer median8.4%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Spectral AI

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.